Enhancing Efficacy of Chemotherapy in Triple Negatiave/Basal-like Breast Cancer by Targeting Macrophages: A Multicenter Phase Ib/II study of PLX3397 and Eribulin in Patients with Metastatic Breast Cancer
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
University of California - San Francisco
Start Date
August 8, 2013
End Date
August 7, 2018
Administered By
Duke Cancer Institute
Awarded By
University of California - San Francisco
Start Date
August 8, 2013
End Date
August 7, 2018